IFNα/β and autophagy: Tug-of-war between HCV and the host

Jiaren Sun, Mayura M. Desai, Lynn Soong, J. H.James Ou

Research output: Contribution to journalShort surveypeer-review

15 Scopus citations


Hepatitis C virus (HCV) infects approximately 130 million people worldwide. The clinical sequelae of this chronic disease include cirrhosis, functional failure and carcinoma of the liver. HCV induces autophagy, a fundamental cellular process for maintaining homeostasis and mediating innate immune response, and also inhibits autophagic protein degradation and suppresses antiviral immunity. In addition to this ploy, the HCV serine protease composed of the viral nonstructural proteins 3/4A (NS3/4A) can enzymatically digest two cellular proteins, mitochondriaassociated antiviral signaling protein (MAVS) and toll/interleukin-1 receptor domain containing adaptor inducing IFNβ (TRIF). Since these two proteins are the adaptor molecules in the retinoic acid-inducible gene I (RIG-I) and TLR3 pathways, respectively, their cleavage has been suggested as a pivotal mechanism by which HCV blunts the IFNα/β signaling and antiviral responses. Thus far, how HCV perturbs autophagy and copes with IFNα/β in the liver remains unclear.

Original languageEnglish (US)
Pages (from-to)1394-1396
Number of pages3
Issue number11
StatePublished - Nov 2011


  • Autophagy
  • Hepatitis C virus
  • Liver disease
  • NS3/4A protease
  • RIG-I
  • TLR3
  • Transgenic mouse
  • Type I interferon

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology


Dive into the research topics of 'IFNα/β and autophagy: Tug-of-war between HCV and the host'. Together they form a unique fingerprint.

Cite this